NFKB1 and sclerosing cholangitis: Indeed, it has recently been shown that the protective effect of intestinal inflammation on sclerosing cholangitis may be driven by hepatocellular NF-κB activation induced by lipopolysaccharides, which in turn inhibits bile acid metabolism (18).